Intravenous rituximab for the treatment of cancer-associated retinopathy
Authors:
- Chris OrCOChris Or
- David R. CollinsDCDavid R. Collins
- Andrew B. MerkurAMAndrew B. Merkur
- Yujuan WangYWYujuan Wang
- Chi-Chao ChanCCChi-Chao Chan
- Farzin ForooghianFFFarzin Forooghian
- 1 April 2013
- journal article
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 48 (2) , e35-e38
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Autoimmune RetinopathyOphthalmologica, 2012
- B-cell-depleting Therapy in Systemic Lupus ErythematosusThe American Journal of Medicine, 2012
- Optical Coherence Tomography Findings in Autoimmune RetinopathyAmerican Journal of Ophthalmology, 2012
- Cancer-Associated Retinopathy: Update on Pathogenesis and TherapySeminars in Ophthalmology, 2011
- A Case of Autoimmune Retinopathy Associated with Thyroid CarcinomaOcular Immunology and Inflammation, 2010
- Management of Autoimmune Retinopathies With ImmunosuppressionArchives of Ophthalmology (1950), 2009
- Autoimmune retinopathy: A review and summarySeminars in Immunopathology, 2008
- Successful treatment of cancer-associated retinopathy with alemtuzumabJournal of Neuro-Oncology, 2007
- Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2004
- Clinical and immunologic aspects of cancer-associated retinopathyAmerican Journal of Ophthalmology, 2004